ABCB1 p.Asp1200Asn

[switch to full view]
Comments [show]
Publications
PMID: 16442101 [PubMed] Frelet A et al: "Insight in eukaryotic ABC transporter function by mutation analysis."
No. Sentence Comment
165 But Hrycyna et al. [9] reported that the mutations D555N and D1200N (D555 and D1200 are presumably involved in Mg2+ binding) resulted in impaired nucleotide photoaffinity labeling only for D555N.
X
ABCB1 p.Asp1200Asn 16442101:165:61
status: NEW
Login to comment

PMID: 10529234 [PubMed] Hrycyna CA et al: "Both ATP sites of human P-glycoprotein are essential but not symmetric."
No. Sentence Comment
71 The D1200N mutant DNA was constructed similarly with two internal complementary primers, each containing the mutation of interest (G f A at position 3598 for D1200N).
X
ABCB1 p.Asp1200Asn 10529234:71:4
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:71:158
status: NEW
Login to comment

72 The coding sequence for the D1200N mutant primer was 5'-ATATTTTGCTTTTGAATGAAG-3'.
X
ABCB1 p.Asp1200Asn 10529234:72:28
status: NEW
Login to comment

78 The resulting plasmid was named pTM1-MDR1-D1200N.
X
ABCB1 p.Asp1200Asn 10529234:78:44
status: NEW
Login to comment

79 The D555N/D1200N double mutant was constructed exactly like pTM1-MDR1-D1200N except that pTM1-MDR1-D555N was used as the template for the first PCR reaction.
X
ABCB1 p.Asp1200Asn 10529234:79:10
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:79:70
status: NEW
Login to comment

80 The resulting expression plasmid was named pTM1-MDR1-D555N/ D1200N.
X
ABCB1 p.Asp1200Asn 10529234:80:60
status: NEW
Login to comment

106 Recombinant vaccinia viruses vvT7MDR1(WT) (wild-type P-gp), vvMDR1-CM (P-gp-D1200N), vvMDR1-Mg5 (P-gp-D555N), and vvMDR1-DM (P-gp-D555N/D1200N) were constructed as previously described (28) from the corresponding pTM1-MDR1 vectors described above.
X
ABCB1 p.Asp1200Asn 10529234:106:76
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:106:136
status: NEW
Login to comment

163 The two mutants, designated P-gp-D555N and P-gp-D1200N, were constructed by site-directed mutagenesis, cloned into pTM1-MDR1, and transiently expressed in HeLa cells coinfected with the vaccinia virus vTF7-3 as described under Experimental Procedures.
X
ABCB1 p.Asp1200Asn 10529234:163:48
status: NEW
Login to comment

165 Total extracts from HeLa cells expressing wild-type P-gp, P-gp-D555N, P-gp-D1200N, and the double mutant P-gp-D555N/ D1200N were subjected to immunoblot analysis with the monoclonal antibody C219 (32).
X
ABCB1 p.Asp1200Asn 10529234:165:75
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:165:117
status: NEW
Login to comment

166 While P-gp-D1200N was found to be expressed at a level comparable to wild-type P-gp, in this preparation of membranes it appears that less P-gp-D555N and P-gp D555N/D1200N were expressed compared to wild-type.
X
ABCB1 p.Asp1200Asn 10529234:166:11
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:166:165
status: NEW
Login to comment

169 Fluorescent substrate accumulation assays were performed on intact HeLa cells expressing wild-type P-gp, P-gp-D555N, and P-gp-D1200N with the P-gp substrate calcein-AM.
X
ABCB1 p.Asp1200Asn 10529234:169:126
status: NEW
Login to comment

170 HeLa cells were transiently infected with vTF7-3 and transfected with pTM1-MDR1 (wild-type), pTM1-MDR1-D555N, and pTM1-MDR1-D1200N, with pTM1 as the negative control, and allowed to incubate for approximately 24 h. After incubation with 0.5 µM calcein-AM for 10 min, cells expressing wild-type P-gp accumulated less substrate than the pTM1 control as measured by a decrease in fluorescence intensity (Figure 2).
X
ABCB1 p.Asp1200Asn 10529234:170:124
status: NEW
Login to comment

172 Strikingly, the two Walker B mutants P-gp-D555N and P-gp-D1200N were completely devoid of transport function (Figure 2).
X
ABCB1 p.Asp1200Asn 10529234:172:57
status: NEW
Login to comment

178 The ability of Walker B mutants P-gp-D555N, P-gp-D1200N, and P-gp-D555N/D1200N to hydrolyze ATP either in the absence (basal) or presence (drug-stimulated) of 25 µM verapamil was measured as the vanadate-sensitive release of inorganic phosphate from Mg2+ ‚ATP as described under Experimental Procedures, with membrane preparations from vTF7-3-infected HeLa cells alone or vTF7-3-infected cells that were coinfected with recombinant vaccinia viruses encoding wild-type P-gp, P-gp-D555N, P-gp-D1200N, and P-gp-D555N/D1200N.
X
ABCB1 p.Asp1200Asn 10529234:178:49
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:178:72
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:178:503
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:178:526
status: NEW
Login to comment

184 (A) vTF7-3-infected-transfected HeLa cells (500 000) expressing wild-type P-gp (bold line), P-gp-D555N (---), and P-gp-D1200N (-‚-) were subjected to FACS analysis after incubation with 5 µg of MRK-16 for 30 min at 37 °C, washing (200g, 5 min), and staining with FITC-conjugated anti-mouse IgG secondary antibody (1 µg) for 30 min at 37 °C.
X
ABCB1 p.Asp1200Asn 10529234:184:119
status: NEW
Login to comment

188 HeLa cells were infected with vTF7-3 recombinant vaccinia viruses expressing wild-type P-gp, P-gp-D555N, P-gp-D1200N, and P-gp-D555N/D12000N and harvested after 48 h. Membranes (1 µg/lane) prepared from these cells were subjected to SDS-PAGE and immunoblotting with monoclonal antibody C219 (1:1500).
X
ABCB1 p.Asp1200Asn 10529234:188:110
status: NEW
Login to comment

191 HeLa cells were infected with vTF7-3 and transfected with pTM1-MDR1 (wild type), pTM1-MDR1-D555N, and pTM1-MDR1-D1200N for 24 h. Calcein (0.5 µM) accumulation was determined in these cells by FACS after a 10 min incubation at 37 °C in the presence (thin line) and absence (bold line) of 2 µM cyclosporin A. vTF7-3-infected cells transfected with pTM1 vector DNA were included as a negative control.
X
ABCB1 p.Asp1200Asn 10529234:191:112
status: NEW
Login to comment

195 Crude membrane preparations derived from HeLa cells infected with vTF7-3 alone and from cells coinfected with recombinant vaccinia viruses encoding wild-type P-gp, P-gp-D555N, P-gp-D1200N, and P-gp-D555N/D1200N were labeled with [125I]IAAP at a concentration of 7.5 nM, immunoprecipitated with anti-P-gp polyclonal antibody PEPG-2 (33), and subjected to SDS-PAGE and autoradiography (Figure 4A).
X
ABCB1 p.Asp1200Asn 10529234:195:181
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:195:204
status: NEW
Login to comment

202 To further demonstrate that ATP hydrolysis is essential and to evaluate the roles of the two NBDs for inhibition of [125I]IAAP labeling as a result of vanadate trapping, we analyzed the effects of the Walker B consensus motif mutations D555N, D1200N, and D555N/D1200N.
X
ABCB1 p.Asp1200Asn 10529234:202:243
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:202:261
status: NEW
Login to comment

207 Human P-gp-D555N and P-gp-D1200N Differ Dramatically in Their Ability To Be Labeled with [R-32P]-8-Azido-ATP.
X
ABCB1 p.Asp1200Asn 10529234:207:26
status: NEW
Login to comment

210 Membrane preparations from HeLa cells infected with vTF7-3 and coinfected with vvT7MDR1 (WT) (wild-type P-gp), vvMDR1-CM (P-gp-D1200N), vvMDR1-Mg5 (P-gp-D555N), or vvMDR1-DM (P-gp-D555N/D1200N).
X
ABCB1 p.Asp1200Asn 10529234:210:127
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:210:186
status: NEW
Login to comment

216 (A) Wild type and the mutant P-gps D555N, D1200N, and D555N/1200N were expressed in HeLa cells by use of recombinant vaccinia viruses, and crude membranes (45 µg) were used for [125I]IAAP photoaffinity labeling.
X
ABCB1 p.Asp1200Asn 10529234:216:42
status: NEW
Login to comment

220 Wild-type (b) and mutant Pgps, D555N ([), D1200N (4), and D555N/D1200N (O) were expressed in HeLa cells by use of recombinant vaccinia viruses and crude membranes (15 µg) were used for [125I]IAAP labeling in the presence of varying concentrations of vanadate, 5 mM MgCl2, and 2.5 mM ATP.
X
ABCB1 p.Asp1200Asn 10529234:220:42
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:220:64
status: NEW
Login to comment

225 Membranes expressing wild-type P-gp and P-gp-D1200N were labeled with [R-32 P]-8-azido-ATP.
X
ABCB1 p.Asp1200Asn 10529234:225:45
status: NEW
Login to comment

227 Strikingly, the [R-32P]-8-azido-ATP labeling observed in membranes expressing P-gp-D555N and P-gp-D555N/D1200N was severely impaired.
X
ABCB1 p.Asp1200Asn 10529234:227:104
status: NEW
Login to comment

238 As can be seen, the N-half of P-gp is labeled predominantly in the wild-type and D1200N proteins (Figure 6A).
X
ABCB1 p.Asp1200Asn 10529234:238:81
status: NEW
Login to comment

251 Crude membrane preparations (50 µg) from HeLa cells infected with vTF7-3 and recombinant vaccinia viruses expressing wild-type P-gp, P-gp-D555N, P-gp-D1200N, or P-gp-D555N/ D1200N were photoaffinity-labeled on ice (0 °C) with either (A) 2.5 µM or (B) 77.5 µM [R-32P]-8-azido-ATP.
X
ABCB1 p.Asp1200Asn 10529234:251:155
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:251:178
status: NEW
Login to comment

255 Crude membrane preparations (50-60 µg) from HeLa cells infected with vTF7-3 and recombinant vaccinia viruses expressing wild-type P-gp, P-gp-D555N, P-gp-D1200N, or P-gp-D555N/D1200N were photoaffinity-labeled with either (A) [R-32P]- 8-azido-ATP (2.5 µM) or (B) [125I]IAAP (15 nM) as described in the legend to Figures 4 and 5.
X
ABCB1 p.Asp1200Asn 10529234:255:158
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:255:180
status: NEW
Login to comment

270 There was no apparent increase in the amount of label associated with the C-half of P-gp-D1200N under hydrolysis conditions, suggesting that the mutant is incapable of catalyzing even one ATP hydrolysis reaction (Figure 7B, lane 8).
X
ABCB1 p.Asp1200Asn 10529234:270:89
status: NEW
Login to comment

271 However, the N-half of P-gp-D1200N retained its ability to be labeled with [R-32P]-8-azido-ATP (Figure 7B, lanes 6 and 8) under both binding and hydrolysis conditions.
X
ABCB1 p.Asp1200Asn 10529234:271:28
status: NEW
Login to comment

272 Similar to P-gp-D1200N, P-gp-D555N and P-gp-D555N/D1200N were not capable of being vanadate-trapped, confirming their lack of ATPase activity (data not shown).
X
ABCB1 p.Asp1200Asn 10529234:272:16
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:272:50
status: NEW
Login to comment

277 Wild-Type and D1200N Human P-gp Proteins Do Not Differ Significantly in Their Apparent Affinity for ATP.
X
ABCB1 p.Asp1200Asn 10529234:277:14
status: NEW
Login to comment

279 The specific P-gp bands were quantified by phosphorimaging and the data were analyzed as described under Experimental FIGURE 7: [R-32P]-8-Azido-ATP photoaffinity labeling and vanadate trapping of wild-type and P-gp-D1200N from HeLa cell membranes.
X
ABCB1 p.Asp1200Asn 10529234:279:215
status: NEW
Login to comment

280 Crude membrane preparations (100 µg) from HeLa cells infected with vTF7-3 and the recombinant vaccinia virus expressing wild-type or P-gp-D1200N were photoaffinity-labeled with 2.5 µM [R-32P]-8-azido-ATP for 10 min.
X
ABCB1 p.Asp1200Asn 10529234:280:143
status: NEW
Login to comment

286 (B) Examination of wild-type P-gp (lanes 1-4) and D1200N P-gp (lanes 5-8) under [R-32P]-8-azido-ATP hydrolysis/binding conditions: lanes 1 and 5, 0 °C, (-) trypsin, (-) 300 µM vanadate; lanes 2 and 6, 0 °C, (+) trypsin, (-) 300 µM vanadate; lanes 3 and 7, 37 °C, (+) 300 µM vanadate, (+) 25 µM verapamil; lanes 4 and 8, 37 °C, (+) 300 µM vanadate, (+) 25 µM verapamil, (+) trypsin.
X
ABCB1 p.Asp1200Asn 10529234:286:50
status: NEW
Login to comment

293 These data suggest that the wild-type and P-gp D1200N mutant proteins have similar apparent affinities for ATP.
X
ABCB1 p.Asp1200Asn 10529234:293:47
status: NEW
Login to comment

297 To determine if conformational differences exist between active wild-type Pgp and inactive P-gp-D555N and P-gp-D1200N, the reactivity of these constructs expressed transiently in HeLa cells was assessed by use of the conformation-sensitive monoclonal anti-human P-gp antibody UIC2 (5, 45).
X
ABCB1 p.Asp1200Asn 10529234:297:111
status: NEW
Login to comment

300 Furthermore, the UIC2 reactivity of cells expressing either P-gp-D555N and P-gp-D1200N is indistinguishable from each other, in either the presence or absence of cyclosporin A, and is equivalent to that of the cyclosporin A-treated wild-type-expressing cells.
X
ABCB1 p.Asp1200Asn 10529234:300:80
status: NEW
Login to comment

301 These UIC2 reactivity data, taken together with the ATPase data that demonstrated complete abrogation of ATPase activity for the D555N and D1200N P-gp proteins (Figure 3) and the ATP labeling data that demonstrated marked differences in the ability of these molecules to bind ATP (Figure 5), strongly suggest that the intrinsic ability of the P-gp molecule to hydrolyze ATP or associate with hydrolysis products accounts for the difference in conformation detected by UIC2.
X
ABCB1 p.Asp1200Asn 10529234:301:139
status: NEW
Login to comment

304 Crude membrane preparations from HeLa cells expressing either wild-type P-gp or P-gp-D1200N were incubated and photoaffinity-labeled in the presence of increasing MgCl2 (0-10 mM) followed by immunoprecipitation with PEPG-2, SDS-PAGE, and autoradiography.
X
ABCB1 p.Asp1200Asn 10529234:304:85
status: NEW
Login to comment

306 Figure 9 demonstrates that for both the wild-type P-gp (Figure 9A) and P-gp-D1200N (Figure 9B) the labeling with [R-32P]-8-azido-ATP increased in a magnesium concentration-dependent manner with half-maximum incorporation at 152.9 ( 29.9 µM for wild-type P-gp and 161.5 ( 39.7 µM for P-gp-D1200N.
X
ABCB1 p.Asp1200Asn 10529234:306:76
status: NEW
X
ABCB1 p.Asp1200Asn 10529234:306:298
status: NEW
Login to comment

310 Taken together, these data demonstrate that the P-gp-D1200N and wild-type P-gp proteins have similar requirements for Mg2+ and that the requirement is 50-60 times greater than the [R-32 P]-8-azido-ATP concentration (2.5 µM) used in the assay, suggesting another role for magnesium in addition to complexing with ATP in the active site.
X
ABCB1 p.Asp1200Asn 10529234:310:53
status: NEW
Login to comment

315 FIGURE 8: UIC2 reactivity shift induced by incubation with cyclosporin A. vTF7-3-infected-transfected HeLa cells expressing wild-type P-gp, P-gp-D555N, or P-gp-D1200N were subjected to FACS analysis after staining with UIC2 in the presence (thin line) and absence (bold line) of 5 µM cyclosporin A.
X
ABCB1 p.Asp1200Asn 10529234:315:160
status: NEW
Login to comment

335 As shown in Figure 11, both the wild-type (WT) P-gp and the P-gp-1N/1N molecules were labeled FIGURE 9: Effect of increasing concentrations of MgCl2 on [R-32P]- 8-azido-ATP photoaffinity labeling of wild-type P-gp and P-gp- D1200N in membrane preparations from HeLa cells.
X
ABCB1 p.Asp1200Asn 10529234:335:224
status: NEW
Login to comment

336 Crude membrane preparations (75 µg) from HeLa cells expressing (A) wild-type P-gp and (B) P-gp-D1200N were photoaffinity-labeled with 2.5 µM [R-32P]-8-azido-ATP on ice (0 °C) in the presence of increasing concentrations of MgCl2 (0-10 mM).
X
ABCB1 p.Asp1200Asn 10529234:336:100
status: NEW
Login to comment

354 These mutations at positions D555N and D1200N, made separately or in concert, did not affect the ability of the transporter to bind substrate but completely abrogated transport function and both basal and drug-stimulated ATPase activity.
X
ABCB1 p.Asp1200Asn 10529234:354:39
status: NEW
Login to comment

365 Whereas P-gp-D1200N, the mutant transporter with a C-terminal amino acid substitution, labels comparably to the wild-type protein, P-gp-D555N, containing a homologous N-terminal mutation, is severely impaired in its ability to be labeled with [R-32P]-8-azido-ATP.
X
ABCB1 p.Asp1200Asn 10529234:365:13
status: NEW
Login to comment

368 After mild trypsinization, it was apparent that the N-half is predominantly labeled in the D1200N and wild-type proteins, whereas little to no labeling of the N-half of the P-gp-D555N was observed.
X
ABCB1 p.Asp1200Asn 10529234:368:91
status: NEW
Login to comment

393 This model is also consistent with the data from the nonfunctional Walker B motif mutants, P-gp-D555N and P-gp-D1200N.
X
ABCB1 p.Asp1200Asn 10529234:393:111
status: NEW
Login to comment

397 In the case of P-gp-D1200N, although the N-half can bind ATP, the C-half is disabled by the mutation and the molecule remains hydrolysis-incompetent.
X
ABCB1 p.Asp1200Asn 10529234:397:20
status: NEW
Login to comment

PMID: 10758006 [PubMed] Julien M et al: "Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity."
No. Sentence Comment
232 Additional photolabeling experiments using the Walker B mutants D555N and D1200N showed that in contrast to results from Urbatsch et al. (15), only the D1200N mutant can be photolabeled under binding conditions with all the label being present at the NBD1 (16).
X
ABCB1 p.Asp1200Asn 10758006:232:74
status: NEW
X
ABCB1 p.Asp1200Asn 10758006:232:152
status: NEW
Login to comment

PMID: 11287418 [PubMed] Sauna ZE et al: "Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis."
No. Sentence Comment
55 Preparation of Crude Membranes from HeLa Cells Expressing Mutant and Wild-type Pgp-A 70-80% confluent monolayer of HeLa cells was infected with vTF7-3 and transfected with pTM1-MDR1 (wild type) or pTM1-MDR1 bearing the homologous mutations at positions 555 (D555N) and 1200 (D1200N) as described previously (9).
X
ABCB1 p.Asp1200Asn 11287418:55:275
status: NEW
Login to comment

56 The vaccinia virus expression vectors pTM1-MDR1 (wild type) and pTM1-MDR1(D555N) and pTM1-MDR1(D1200N) were provided by C. A. Hrycyna and M. M. Gottesman, Laboratory of Cell Biology, NCI, National Institutes of Health, Bethesda.
X
ABCB1 p.Asp1200Asn 11287418:56:95
status: NEW
Login to comment

224 The Pgp mutants D555N and D1200N in Walker B domain of ATP sites do not show Vi-induced trapping of [␣-32 P]8-azido-ADP using either [␣-32 P]8-azido-ADP or [␣-32 P]8-azido-ATP.
X
ABCB1 p.Asp1200Asn 11287418:224:26
status: NEW
Login to comment

225 Crude membranes were prepared from HeLa cells transiently expressing the pTM1-MDR1 (designated wild type) and pTM1-MDR1 bearing the homologous mutations in Walker B region of ATP sites at positions 555 and 1200 (designated D555N and D1200N), respectively.
X
ABCB1 p.Asp1200Asn 11287418:225:233
status: NEW
Login to comment

230 Lane 1, wild-type Pgp membranes labeled with [␣-32 P]8-azido-ATP; lane 2, D555N membranes labeled with [␣-32 P]8-azido-ATP; lane 3, D1200N membranes labeled with [␣-32 P]8-azido-ATP; lane 4, wild-type membranes labeled with [␣-32 P]8-azido-ADP; lane 5, D555N membranes labeled with [␣-32 P]8-azido-ADP; and lane 6, D1200N membranes labeled with [␣-32 P]8-azido-ADP.
X
ABCB1 p.Asp1200Asn 11287418:230:146
status: NEW
X
ABCB1 p.Asp1200Asn 11287418:230:350
status: NEW
Login to comment

290 The mutations in either the N-terminal ATP site (D555N) or the C-terminal site (D1200N) abolish Vi-induced trapping of [␣-32 P]8-azido-ADP by both the hydrolysis and non-hydrolysis routes (Fig. 6).
X
ABCB1 p.Asp1200Asn 11287418:290:80
status: NEW
Login to comment

PMID: 9788623 [PubMed] Russ G et al: "P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells."
No. Sentence Comment
67 Further rVVs were used to express P-glycoprotein |MDRI(T7)] and P-glycoprotein mutants (NM- D555N, CM-D1200N, and DM-D555N + D1200N), under the control of the T7 promoter (14).
X
ABCB1 p.Asp1200Asn 9788623:67:102
status: NEW
X
ABCB1 p.Asp1200Asn 9788623:67:125
status: NEW
Login to comment

109 The introduced mutations alter one or both of highly conserved Asp residues located, respectively, within Walker B regions of either NH2-terminal (D555N) or COOH-terminal (D1200N) ATP binding/utilization sites that are believed to be involved in binding to Mg2+.
X
ABCB1 p.Asp1200Asn 9788623:109:172
status: NEW
Login to comment

64 Further rVVs were used to express P-glycoprotein |MDRI(T7)] and P-glycoprotein mutants (NM- D555N, CM-D1200N, and DM-D555N + D1200N), under the control of the T7 promoter (14).
X
ABCB1 p.Asp1200Asn 9788623:64:102
status: NEW
X
ABCB1 p.Asp1200Asn 9788623:64:125
status: NEW
Login to comment

105 To determine the requirement for a functional P-glycoprotein, we used rVVs expressing three mutated forms of the protein under the control of the T7 promoter, termed CM, NM, and DM. The introduced mutations alter one or both of highly conserved Asp residues located, respectively, within Walker B regions of either NH2-terminal (D555N) or COOH-terminal (D1200N) ATP binding/utilization sites that are believed to be involved in binding to Mg2+.
X
ABCB1 p.Asp1200Asn 9788623:105:354
status: NEW
Login to comment